Dr. Reddy’s Laboratories Ltd. on Wednesday announced the launch of Lenalidomide Capsules in the United States market. According to the company, this is the therapeutic equivalent generic version of ...
RALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ -- Accord Healthcare, Inc., a leading U.S. pharmaceutical company, today announced the launch of Lenalidomide Capsules in the United States, reinforcing the ...
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of a first generic ...
Dr. Reddy’s is introducing lenalidomide capsules, a generic of Revlimid. With this volume-limited launch, Dr. Reddy’s is eligible for first to market, 180 days of generic drug exclusivity for ...
The Company also received tentative approval for the 5mg, 10mg, 15mg, and 25mg strengths. Dr. Reddy’s Laboratories announced that it has received final approval from the Food and Drug Administration ...
Lupin has received approval from the Food and Drug Administration for lenalidomide capsules, 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg and 25 mg, which are the generic of Bristol-Myers Squibb's Revlimid. The ...
Zydus Lifesciences share price was flat in early trade on March 8. The company has received final approval from the United States Food and Drug Administration (USFDA) for Lenalidomide Capsules, 2.5 mg ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), today ...
The FDA notified the public of an increased risk of second primary malignancies in patients with newly-diagnosed multiple myeloma who received Revlimid (lenalidomide capsules; Celgene). This update is ...
MUMBAI, India, Dec. 11, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA) ("Cipla") today announced the settlement of its litigation with Celgene Corporation, and wholly owned subsidiary ...
Lenalidomide, a thalidomide analogue, can cause severe, life-threatening birth defects or embryo-fetal death if used during pregnancy. Lenalidomide capsules are contraindicated in pregnancy. Pregnancy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results